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Renal Cell Carcinoma
• Cancerous adenocarcinomas that appear in the renal 
tubular epithelium
• Usually occurs in patients who are 50-70 years old
• Accounts for 80% of renal tumors 
(El- Feky, M., 2021)
• Incidence rate increases about 2.4% each year due to 
incidental diagnosis 
(Cernic et al., 2021) 
• Can occur from smoking, obesity, dialysis related cystic 
disease, treatment that uses a chemotherapy agent 
(Cyclophosphamide), hypertension, or after a renal 
transplant
• Clinical presentation usually consists of blood in the 
urine, abdominal pain or palpable abdominal mass 
• Partial nephrectomy is usually the treatment of choice 
but cryoablation is done if surgery cannot be performed
(El- Feky, M., 2021)
Imaging
• All images were taken from a CT scan of a renal mass 
in the upper pole of the right kidney
Percutaneous Renal Cryoablation 
Study
• A qualitative study was conducted by two radiologists 
to examine the safety and efficacy of cryoablation 
• 174 renal tumors were treated by CT guided 
cryoablations between February of 2011 and June of 
2020
• Most of the patients were placed in prone position and 
adjusted due to anatomy of kidney
• Biopsies were previously performed on all tumors 
included in the study
(Cernic et al., 2021)
How the Procedure was performed
• 17 Gauge IceSphere or 17 Gauge IceRod cryoprobe 
were used 
• Amount of cryoprobes depended on size of tumor
• One probe is used for every one – two centimeters of 
tumor
• 10 minute freezing time, then passive 9 minutes, then 
one minute active thaw: protocol was repeated
• CT imaging was done at 5 and 10 minutes to evaluate 
ice formation
• If ice did not form around whole tumor, additional 
cryoprobes were inserted
• Non contrast CT performed after removal of 
cryoprobes
• Procedural success, effectiveness and complications 
were evaluated for each procedure
(Cernic et al., 2021)
• This graph represents the overall survival rate of 
patients 60 months following their procedure. The y-
axis represents the survival probability and the x-axis 
represents the time in months
• As the time increased after the procedure, the survival 
probability slightly decreased but did not reach lower 
than 75% 60 months post procedure
(Cernic et al., 2021)
Advantages
• Can be used in conjunction with immunotherapies
• Very high accuracy due to ice ball formation which can 
be depicted on a CT scan
• Shorter recovery time because procedure is not as 
invasive 
• Surrounding tissue is spared 
(Ablative Oncology Center, n.d.)
• Used as a vaccination tool by activating immune 
responses to the tumors cells
(Yakkala et al., 2020)
Conclusion
Cryoablation is a safe and accurate procedure performed in 
Interventional Radiology to treat cancer for those who are 
not surgical candidates. This procedure can be performed 
on numerous types of cancer but renal cell carcinoma has 
been the main focus of the study. The results from this 
study conclude that cryoablation can be performed without 
complications and will remain effective years after it is 
performed without reoccurrence of the tumor. 
Introduction
Interventional Radiology (IR) is an advanced imaging 
modality that utilizes a sterile environment to intervene and 
treat a disease process therapeutically. IR is able to reduce 
hospital stays by avoiding surgery while also reducing 
medical costs. IR consists of two parts which are 
interventional and radiography. The interventional part is 
described as using wires and catheters to improve a 
patients condition. The radiography part provides the 
radiologist with guidance during the procedure by creating 
a visual image of the patients anatomy. This image could 
be a single image or live imaging which shows the 
advancement of the wire as it moves. Radiography is also 
useful because it is used as documentation of the steps 
completed during the procedure.
(Long, Rollins, & Smith,  2019)
Cryoablation is a procedure performed in IR in conjunction 
with computed tomography (CT) guidance to treat 
numerous types of cancer. In the procedure, cold 
temperatures are used to kill cancer cells while also 
preventing growth of the cancer.
Cryoablation
• A cryoprobe is inserted into a cancerous tumor under 
CT guidance to provide real time accuracy of probe 
insertion
• Argon gas is injected through the probe which freezes 
the tumor
(Hayek & Kastler, 2020)
• Temperatures must be below -40 degrees C to achieve 
cell death
• The tissue is continuously thawed and refrozen until 
necrosis occurs
• The frozen tumor is left within the body which releases 
antigens therefore triggering an immune response
• The antigens could kill future cancer cells and alleviate 
ones pain or symptoms from the tumor
(Yakkala, Denys, Kandalaft, & Duran, 2020)
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Example of iceball formation on tumor
(Allen & Remer, 2010) 
The cryoprobe is inserted into 
the renal mass to confirm the 
correct placement of probe
The renal mass is located 
on the kidney and marked 
with a red “X”
Image C shows two cryoprobes inserted 
into the tumor from a sagittal view







• Procedural success was achieved in 98.3% of tumors 
(171/174)
• Effectiveness of treatments was 95.3% which then 
increased to 98.2% after retreats
• Complication rate was 29.8%
• At 1 year after the procedure there was 100% recurrence-
free survival
• At 3 years there was 95.3% recurrence-free survival
• At 5 years there was 88.6% recurrence-free survival




• A primary treatment for numerous types of cancer:
• Relives pain and symptoms caused by the cancer
• Done if patient is not a surgical canidate
(Mayo Clinic, 2020)
The image on the 
left shows two 
cryoprobes
(Ablative Oncology 
Center, n.d.)
